Page 1

Sl . No. 1 SYNGENE INTERNATIONAL LIMITED CIN : L85110KA1993PLC014937 Website : www.syngeneintl.com Registered office : Biocon SEZ , Biocon Park , Plot No. 2 & 3 , Bommasandra Industrial Area IV Phase , Jigani Link Road , Bommasandra , Bangalore - 560099 Income a ) Revenue from operations b ) Other Income Total Income STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30 JUNE 2021 Particulars 3 months ended 30 June 2021 Preceding 3 months ended 31 March 2021 ( Unaudited ) ( Audited ) ( Refer note 4 ) ( Rs . in million , except per share data ) Corresponding Previous year 3 months ended in the previous year 30 June 2020 ( Unaudited ) ended 31 March 2021 ( Audited ) 5,937 6,581 4,202 21,794 123 184 153 646 6,060 6,765 4,355 22,440 2 Expenses a ) Cost of chemicals , reagents and consumables consumed 2,064 1,643 927 5,517 b ) Changes in inventories of finished goods and work - in - progress ( 118 ) ( 28 ) ( 30 ) ( 252 ) c ) Employee benefits expense 1,679 1,773 1,365 6,415 d ) Finance costs 79 66 74 277 e ) Depreciation and amortisation expense 747 700 661 2,745 f ) Other expenses 822 1,088 665 3,585 g ) Foreign exchange fluctuation ( gain ) / loss , net ( 154 ) ( 47 ) 33 ( 171 ) Total expenses 5,119 5,195 3,695 18,116 34567∞ Profit before tax and exceptional item ( 1-2 ) Exceptional item [ refer note 3 ] Profit before tax ( 3-4 ) Tax expense # [ refer note 3 ] Profit for the period / year ( 5-6 ) 941 1,570 660 4,324 ( 350 ) ( 350 ) 941 1,920 660 4,674 172 315 82 637 769 1,605 578 4,037 8 Other comprehensive income ( A ) ( i ) Items that will not be reclassified to profit or loss ( 4 ) ( ii ) Income tax relating to items that will not be reclassified to profit or loss 1 ( B ) ( i ) Items that will be reclassified to profit or loss ( 177 ) 401 ( ii ) Income tax relating to items that will be reclassified to profit or loss 20 26 Other comprehensive income for the period / year , net of taxes ( 154 ) $ ॰ ཌཱུ ® ༔ ( 48 ) 6 ( 30 ) 10 ( 1 ) 5 368 2,375 ( 59 ) ( 100 ) ( 444 ) 273 1,906 9 Total comprehensive income for the period / year ( 7 + 8 ) 615 10 Paid - up equity share capital ( Face value of Rs . 10 each ) 4,008 1,909 4,000 851 4,000 5,943 4,000 11 Reserves excluding revaluation reserves as per balance sheet i.e. ' Other Equity ' 24,183 12 Earnings per share ( of Rs.10 each ) ( not annualised ) ( not annualised ) ( not annualised ) ( annualised ) a ) Basic 1.90 b ) Diluted 1.88 4.03 4.00 1.46 10.15 1.45 10.08 #Includes credit for reversal of tax provision for earlier years amounting to Rs . 105 million for the year ended 31 March 2021 . See accompanying notes to the financial results